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TISSUE ENGINEERS HIGHLIGHT mesenchymal stem cells (MSCs) because of their long-term viability, ability to renew, and potential to differentiate into diverse cell types. MSCs come from blood and various tissues, including bone marrow, umbilical cord blood, periosteum, amniotic fluid, skeletal muscle, synovium, and adipose tissues (5, 6, 20, 27a, 50, 53, 54, 57) . MSCs can differentiate into several types of cells including chondrocytes, osteocytes, adipocytes, neuron, cardiomyocytes, and smooth muscle cells (SMCs; Refs. 11, 16, 23, 26, 47, 53, 55) . Transforming growth factor-␤ (TGF-␤; Refs. 28, 64) , sphingosylphosphotylcholine (SPC; Refs. 22, 23) , thromboxane A 2 (26) , mechanical stress (32) , coculture with vascular endothelial cells (4) , and PGF 2␣ (35) can cause MSCs to differentiate into SMCs.
The specific expression of contractile proteins; for example, calponin, ␣-smooth muscle actin (␣-SMA), smooth musclemyosin heavy chain (SM-MHC), smoothelin, and h-caldesmon (23, 49, 56) characterizes the phenotypes of SMCs. These proteins are closely related to vascular development and cardiovascular diseases including atherosclerosis and hypertension (37, 49) .
The expression of ion channels that regulate the contractile response, such as L-type Ca 2ϩ channels, big-conductance Ca 2ϩ -activated K ϩ (BK Ca ) channels, and voltage-dependent K ϩ (K v ) channels, also discriminates vascular SMCs from other cells. L-type Ca 2ϩ channels play a key role in vascular smooth muscle contraction by inducing the influx of extracellular Ca 2ϩ (15, 17) . The characteristics of vascular Ca 2ϩ channels are relatively small amplitude and slow activation and inactivation processes compared with neurons and cardiac myocytes. In SMCs, particularly vascular SMCs, BK Ca channels are more highly expressed than small-conductance Ca 2ϩ -activated K ϩ (SK Ca ) and intermediate-conductance Ca 2ϩ -activated K ϩ (IK Ca ) channels (48) . The physiological role of BK Ca channels in vascular SMCs maintains myogenic tone. Membrane depolarization and intracellular Ca 2ϩ activate BK Ca channels counteracting the membrane depolarization and constriction caused by vasoconstrictors and pressure (8, 30, 48) . The slow inactivation of K v channels is also a specific characteristic of vascular SMCs. In general, the vascular K v channels slowly decay with a time constant of ϳ1 s at Ͼ40 mV due to their intrinsic inactivation (48, 52) .
Although previous studies clearly revealed that TGF-␤ 1 , SPC, and thromboxane A 2 induced the differentiation of human adipose tissue-derived MSCs (hASCs) into smooth mus-cle-like cells (22, 23, 26) , no studies addressed the functional expression of SMC-specific ion channels in these cells. Therefore, we characterized for the first time the functional expression of ion channels during the TGF-␤ 1 -induced differentiation of hASCs into vascular SMCs and found that differentiated hASCs functionally expressed vascular L-type Ca 2ϩ channels, BK Ca channels, and K v channels.
MATERIALS AND METHODS
Materials. Phosphate-buffered saline, trypsin, ␣-MEM, and fetal bovine serum were purchased from Invitrogen (Carlsbad, CA). Carbachol was purchased from BIOMOL (Plymouth Meeting, PA). Rat tail collagen (type I) was purchased from BD Biosciences (Bedford, MA). BayK 8644, nicardipine, and iberiotoxin were purchased from Tocris Bioscience (Ellisville, MO). Anti-␣-SMA (A2547) and anticalponin (C2687) antibodies were purchased from Sigma-Aldrich (St. Louis, MO). Antibodies against myocardin (ab22621), anti-smoothelin-B (ab8969), anti-h-caldesmon (ab50016), anti-SM-MHC (ab53219), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were purchased from Abcam (Cambridge, MA). Peroxidase-labeled secondary antibodies were purchased from Amersham Biosciences.
Culture of hASCs. Adipose tissue was obtained from elective surgeries with patient's informed written consent as approved by the Fig. 1 . Functional expression of smooth muscle cell (SMC) marker proteins and contractile-response of transforming growth factor-␤1-induced, differentiated human adipose tissue-derived mesenchymal stem cells (hASCs). A: expression of SMC-specific marker proteins in hASCs and transforming growth factor-␤1 (TGF-␤1)-induced, differentiated hASCs was determined by Western blotting. To ensure equal loading of each sample, the expression levels of GAPDH were determined. SM-MHC, smooth myosin heavy chain. B: statistical summary of A. *P Ͻ 0.05 vs. respective controls (w/o; n ϭ 4). C: contractile response of hASCs and TGF-␤1-induced, differentiated hASCs. hASCs were treated with TGF-␤1 in the absence or presence of 10 M SB432542 for 4 days and embedded into collagen gel lattices. Gel contraction was photographed at 24 h by using a digital camera. D: statistical summary of gel contraction, determined by Scion Image software (n ϭ 4). The relative area of the gel lattices was obtained by dividing the area by the initial area of the lattice at each time point. *P Ͻ 0.05 vs. w/o (undifferentiated hASCs). E: undifferentiated hASCs (control) or TGF-␤1-induced, differentiated hASCs were embedded into collagen gel lattices. Collagen gels were exposed to 1 M carbachol or 60 mM KCl for 24 h, and the area of gel lattices was determined at 0 and 24 h. The relative area of the gel lattices was obtained by dividing the area by the initial area of the lattice at 24 h (n ϭ 5). *P Ͻ 0.05, by two-way ANOVA and Scheffé's post hoc test.
Institution Review Board of Pusan National University Hospital. Culture of hASCs was performed in the same way as described previously (42) . Briefly, we washed liposuction tissues more than three times with phosphate-buffered saline and mixed them with an equal volume of collagenase (type I) suspension (1 g/l buffered saline solution buffer with 1% bovine serum albumin) for 60 min at 37°C with shaking. Floating adipocytes were separated from the stromalvascular fraction by centrifugation (300 g for 5 min). The cellular pellet was resuspended in MEM supplemented with 100 U/ml penicillin, 10% fetal bovine serum, and 100 g/ml streptomycin, and cells were plated in dishes for tissue culture at 3,500 cells/cm 2 . The primary hASCs were cultured for 4 or 5 days until they reached confluence, defined as passage "0". hASCs ware used between passages 3 and 10 in our experiments. The hASCs were positive for CD29, CD44, CD73, CD90, and CD105 and negative for CD31, CD34, and CD45. For TGF-␤ 1-induced differentiation of hASCs into SMCs, Fig. 2 
hASCs were seeded onto six-well culture plates at 70% confluence, and they were treated with serum-free ␣-MEM in the absence or presence of 2 ng/ml 
BaCl2, 0.5 MgCl2, 5 TEA-Cl, 10 HEPES, 10 glucose, and 0.01 BayK 8644, adjusted to pH 7.4 with NaOH. The pipette-filled solution contained the following (in mM): 130 CsCl, 10 EGTA, 10 HEPES, and 5 Mg-ATP, adjusted to pH 7.2 with CsOH. Nystatin (200 g/ml) was added to the pipette solution every 2 h.
RT-PCR.
Total cellular RNA was extracted using the mRNA isolation system (Novagen, Darmstadt, Germany), following the manufacturer's guideline. For the RT-PCR analysis, 2-g RNA aliquots were subjected to cDNA synthesis with 200 U MMLV reverse transcriptase (Invitrogen) and 0.5 g oligo (dT) 15 primer (Promega, Madison, WI). For the PCR reaction, 1 l synthesized cDNA was used as a template. PCR primers were used to amplify human BK Ca, Ca 2ϩ , and Kv channels. The thermal cycle profile was as follows: 30-s denaturation at 95°C, 45-s annealing at 46 -65°C, and extension for 45 s at 72°C with 0.5 U of GoTaq DNA polymerase (Promega, Madison, WI). This step was followed by extension step of 72°C for 10 min. For semiquantitative evaluation of expression levels, each PCR was performed for 30 cycles. PCR products were analyzed by 1.2% agarose gel electrophoresis and ethidium bromide staining.
Collagen lattice contraction model. Cell contractility was measured by trypsinized cells in monolayer cultures by treatment with trypsin-EDTA contained solution. Then, cells were counted and resuspended in ␣-MEM at a density of 1 ϫ 10 6 cells/ml. After the cell suspension was mixed with collagen gel solution to make an experimental concentration of 3 mg collagen/ml and 4 ϫ 10 5 cells/ml, we added the cell on the collagen mixture into 12-well culture plates (Nunc, Roskilde, Denmark). Under standard culture conditions, plates were incubated for 1 h to make collagen cell lattices and serum-free ␣-MEM was added into the plates. To initiate collagen gel contraction, lattices were added from the bottom of the culture dishes by gentle agitation at the lattice-dish interface after the addition of activators or inhibitors. The extent of gel contraction was analyzed by detecting the dimensions of the lattice using Scion Image software (compliments of Scion) (23) .
Western blot. To prepare membrane fractions, cells were homogenized in lysis buffer containing the following (in mM): 150 NaCl, 20 Tris·HCl, 50 NaF, 10 EDTA, and 25 NaVO 4, and centrifuged at 12,000 rpm for 10 min. Extract was ultra-centrifuged again at 100,000 g for 1 h to separate the plasma membrane fraction. The pellet was homogenized in lysis buffer containing the following (in mM): 150 NaCl, 20 Tris·HCl, 50 NaF, 10 EDTA, 25 NaVO 4, and 1% Triton X-100. Equal amounts of membrane proteins (30 g) were separated by 8% SDS-PAGE and were electrophoretically transferred to nitrocellulose membranes. Images were captured using a Fuji Imager LAS3000 at 75% of total resolution 10-to 60-s exposure and Multi-Gauge V2.3 system. Hindlimb ischemia, cell transplantation, and blood flow measurement. Athymic nude mice (age 8 -10 wk and weighing 17-22 g) were anesthetized with 160 mg/kg pentobarbital injection. The femoral artery was excised from its proximal origin. After arterial ligation, mice were divided by following experimental groups: the TGF-␤1-treated hASCs, the serum-starved hASCs, and the vehicle group (saline buffer; n ϭ 8 per each group). In each animal, 3 ϫ 10 6 cells (200 l) or medium (DMEM) was injected intramuscularly into four points of the gracilis muscle located in the medial thigh. The extent of necrosis in ischemic hindlimb was recorded on day 28 after surgery. The scores of necrosis were evaluated as follows: 0, limb salvage; 1, toes amputation; 2, foot amputation; and 3, limb amputation. Blood flow of the normal and ischemic limb was measured by laser Doppler perfusion imaging (LDPI) analyzer (Moor instruments, Devon, UK) on days 0, 7, 14, 21, and 28 after hindlimb ischemia. The perfusion of the nonischemic and ischemic limb was presented as colored histogram pixels. Red and blue colors indicate high and low perfusion, respectively. Blood perfusion is expressed as the LDPI index representing the ratio of ischemic vs. nonischemic limb blood flow. A ratio of 1 before operation indicates equal blood perfusion of both legs.
Histological and immunofluorescence analyses. After blood flow measurement was completed over 28 days, hindlimb muscles were removed, formalin-fixed, and paraffin-embedded. Tissues were sliced into 5-m sections, and endothelial cells and SMCs were identified by immunostaining with rat anti-CD31 (550274; BD Pharmingen) and rabbit anti-␣-SMA (ab5694; Abcam) antibodies and then followed by incubation with Alexa 488 goat anti-rat and Alexa 488 goat anti-rabbit secondary antibodies, respectively. The specimens were washed and mounted in Vectashield medium (Vector Laboratories) with DAPI for visualization of nuclei. The stained sections were visualized by laser scanning confocal microscopy (Olympus FluoView FV1000). Capillary density was assessed by counting the number of CD31-positive features per high-power field (ϫ400). Nine mice from each experimental group were analyzed. Twelve randomly selected microscopic fields from three serial sections in each block were examined for the existence of capillary endothelial cells.
Data analysis and statistics. Origin 6.0 software (Microcal Software, Northampton, MA) was used for data analysis. For statistical analysis of the data, Student's t-test, two-way ANOVA, and Scheffé's post hoc test were used to test for statistical significance. The results are expressed as means Ϯ SE. We considered P Ͻ 0.05 to be statistically significant.
RESULTS

TGF-␤ 1 -induced differentiation of hASCs to SMCs.
To test whether hASCs could be differentiated into SMCs by TGF-␤ 1 , we exposed hASCs to TGF-␤ 1 for 4 days. As shown in Fig. 1, A and B , the expression levels of SMC-specific contractile proteins (␣-SMA, calponin, SM-MHC, smoothelin-B, myocardin, and hcaldesmon) and smooth muscle-specific transcription factor myocardin dramatically increased after treatment with TGF-␤ 1 . Although we detected most of the proteins in various SMCs, including visceral and vascular SMCs, vascular SMCs predominantly expressed smoothelin-B (102 kDa); visceral SMCs express a different isoform: smoothelin-A (59 kDa) (23, 59) . We detected only smoothelin-B after the TGF-␤ 1 -induced differentiation of hASCs into SMCs, suggesting that the differentiated SMCs were vascular SMCs.
Collagen lattice contraction assay is useful for measuring the contractile force of cells (23) . As shown in Fig. 1 , C and D, treating the hASCs with TGF-␤ 1 to differentiate them into vascular SMCs reduced the size of the collagen lattices in a time-dependent manner. Undifferentiated hASCs and/or pretreated with the TGF-␤ antagonist SB431542 (10 M) did not contract. We also evaluated the contractility of TGF-␤ 1 -induced, differentiated hASCs after treatment with a contractile agonist (1 M carbachol) and membrane depolarization (60 mM KCl). As shown in Fig. 1E , carbachol or high KCl strongly shrank the collagen lattices of the TGF-␤ 1 -induced, Figure 2 shows the Ba 2ϩ -sensitive inward current in the presence of the L-type Ca 2ϩ channel agonist BayK 8644 (10 M) recorded during the TGF-␤ 1 -induced differentiation of hASCs (Fig. 2, B and D) compared with the lack of inward current in the undifferentiated hASCs (Fig. 2, A and D) . The inward current was almost abolished by the application of the L-type Ca 2ϩ channel inhibitor nicardipine (1 M; Fig. 2B ). These results strongly suggest that L-type Ca 2ϩ currents are highly expressed during the TGF-␤ 1 -induced differentiation of hASCs. Furthermore, the recorded L-type Ca 2ϩ channel amplitude and density were very similar to those of native vascular SMCs (Fig.  2, C and D) , demonstrating that the TGF-␤ 1 -induced, differentiated hASCs shared the characteristics of vascular SMCs. To further evaluate the molecular identity of the observed functional Ca 2ϩ currents, we investigated the expression patterns in undifferentiated hASCs and TGF-␤ 1 -induced, differentiated hASCs with specific primers (Table 1) . Vascular SMCs express the major L-type (Ca v 1.X, specifically Ca v 1.2) Ca 2ϩ channels (43) and a small portion of the T-type (Ca v 3.X) Ca 2ϩ channels. Consistent with these facts, as shown in Fig. 3, A Ca v ␤ 1 subtypes during the TGF-␤ 1 -induced differentiation of hASCs (Fig. 3, C and D) .
Expression of BK Ca channels during TGF-␤ 1 -induced differentiated hASCs. In vascular smooth muscle, the major outward currents activated at positive voltage are composed of BK Ca and K v channels (48) . To identify the expression of BK Ca channels, we applied iberiotoxin (100 nM), a specific BK Ca channel inhibitor, on recorded outward current in hASCs and TGF-␤ 1 -induced, differentiated hASCs. Figure 4 shows the lack of iberiotoxin-sensitive currents in hASCs (Fig. 4, A and  D) and the abundance of noisy iberiotoxin-sensitive currents in TGF-␤ 1 -induced, differentiated hASCs (Fig. 4, B and D) . The current amplitude and electrophysiological characteristics were very similar to those of native vascular SMCs (Fig. 4, C and  D) , suggesting that TGF-␤ 1 -induced hASCs differentiate into vascular SMCs. To further evaluate the molecular identity of the observed BK Ca currents, we investigated the expression patterns of BK Ca channels with specific BK Ca channel primers ( Table 2 ). As shown in Fig. 5, A and B, the TGF-␤ 1 -induced differentiation of hASCs dramatically increased the expression levels of the major BK Ca channel ␣-subtypes (K Ca 1.1) but not the SK Ca channel ␣-subtypes (K Ca 2.X) and IK Ca channel ␣-subtypes (K Ca 3.1). The expression levels of ␤-subtypes were relatively various. The expression of BK Ca ␤ 1 , and BK Ca ␤ 3a subtypes were slightly decreased in TGF-␤ 1 -induced differentiation of hASCs. However, BK Ca ␤ 3e and BK Ca ␤ 3 all subtypes were slightly increased. Consistent with the RT-PCR data, the Western blots also confirmed that the TGF-␤ 1 -induced differentiation of hASCs increased the expression levels of the ␣-subtypes of BK Ca but did not change the expression of the ␤-subtypes of BK Ca (Fig. 5, C and D) .
Expression of K v channels during the TGF-␤ 1 -induced differentiation of hASCs. K v channels, which are activated by membrane depolarization and allow the efflux of K ϩ to repolarize the membrane to the resting potential, are highly expressed in most vascular SMCs (31) . To identify the expression of K v channels, BK Ca channels were inhibited by pretreatment of iberiotoxin (100 nM) in the extracellular solution and inclusion of BAPTA (10 mM), a Ca 2ϩ chelator, in the pipette solution. As shown in Fig. 6 , compared with the lack of K v currents in hASCs (Fig. 6, A and E) , the large K v currents were recorded in TGF-␤ 1 -induced, differentiated hASCs with intrinsic inactivation (Fig. 6, B and E) , which is similar to native vascular SMCs (25, 48) (Fig. 6D) . The general K v channel inhibitors TEA (10 mM) and 4-aminopyridine (4-AP; 10 mM) nearly inhibited the large K v currents recorded in the TGF-␤ 1 -induced, differentiated hASCs (Fig. 6, C and E) . These data also support that the TGF-␤ 1 -induced, differentiated hASCs had the characteristics of vascular SMCs. Expression patterns of the K v channel subtypes in TGF-␤ 1 -induced, differentiated hASCs were investigated with specific primers (Table 3) . As shown in Fig. 7 , the TGF-␤ 1 -induced differentiation of hASCs B: quantitative analysis of the perfusion recovery was performed by LDPI. The LDPI index was evaluated as the ratio of ischemic to nonischemic hindlimb blood perfusion (n ϭ 8 per group). *P Ͻ 0.05 vs. serumstarved hASCs. C: statistical analysis of the necrosis score on day 28 (n ϭ 8 per group). *P Ͻ 0.05. dramatically increased the expression of the specific subtypes known to be expressed in vascular SMCs: K v 1.1, K v 1.2, K v 1.4, K v 1.5, and K v 9.3; the expression of the K v 3.2, K v 4.3, K v 5.1, and K v 6.1 subtypes also increased (Fig. 7, A and B) . The representative Western blotting of the K v 1.2, K v 1.5, and K v 3.2 subtypes also showed increased expression levels in the TGF-␤ 1 -induced, differentiated hASCs (Fig. 7, C and D) .
Transplantation of TGF-␤ 1 -treated hASCs stimulates blood perfusion of ischemic hindlimb through stimulating angiogenesis. To establish the therapeutic impact of TGF-␤ 1 -induced differentiation of hASCs into SMCs, TGF-␤ 1 -treated hASCs, serumstarved hASCs, or saline buffer were intramuscularly injected into the ischemic hindlimb, and blood flow was measured over a period of 4 wk using the LDPI analyzer. Intramuscular injection of TGF-␤ 1 -treated hASCs into the ischemic limb significantly improved blood perfusion, as judged by the LDPI. The LDPI ratio showed significant increase in mice transplanted with TGF-␤ 1 -treated hASCs, compared with the control groups in which serum-starved hASCs or saline buffer was injected (Fig. 8, A and B) . Moreover, transplantation of TGF-␤ 1 -treated hASCs significantly inhibited tissue necrosis and amputation as shown by reduced necrosis score 4 wk after induction of ischemia and cell transplantation, compared with control groups (Fig. 8C) . To assess whether transplantation of TGF-␤ 1 -treated hASCs can stimulate angiogenesis in vivo, we determined densities of capillary and arterioles/arteries in ischemic muscle by immunostaining. CD31-positive capillary density was significantly higher in ischemic limb transplanted with TGF-␤ 1 -treated hASCs than the control groups, which were injected with either serum-starved hASCs or saline buffer (Fig. 9, A and B) . The densities of ␣-SMA-positive blood vessels were increased in ischemic limb injected with TGF-␤ 1 -treated hASCs, compared with the control groups (Fig. 9, A and C) . CD-DiI-labeled hASCs were detected in ␣-SMA-positive blood vessels (Fig.  9D) . These findings of increased densities of CD31-positive capillary and ␣-SMA-positive arterioles/arteries after TGF-␤ 1 -treated hASCs transplantation are consistent with the increased blood perfusion and reduced necrosis in the TGF-␤ 1 -treated hASC-injected ischemic limb.
DISCUSSION
In this study, we directly compared the expression of Ca 2ϩ , BK Ca , and K v channels at the mRNA, protein, and functional levels between undifferentiated hASCs and TGF-␤ 1 -induced, differentiated hASCs. Our results show, based on changes in the expression levels of SMC-marker proteins and ion channels, that treating hASCs with TGF-␤ 1 induced them to differentiate into vascular SMCs.
The Ca 2ϩ channels are classified into three families, Ca v 1 (L-types), Ca v 2 (P/Q, N, and R-types), and Ca v 3 (T-types) channels; L-and T-types Ca 2ϩ channels are expressed in vascular smooth muscle (7, 18) . Among the L-type Ca 2ϩ channels, the Ca v 1.2 (CACNA1C) channel is the dominant isoform in vascular smooth muscle and therefore appears to play an important role in regulating vascular tone and arterial constriction (2, 45) . Currently, the major targets of dihydropyridine Ca 2ϩ channel blockers as antihypertensive drugs are the Ca v 1.2 channels expressed in vascular smooth muscle (43, 66) . Therefore, the specific expression of Ca v 1.2 is an important characteristic of vascular smooth muscle. Our data clearly show, with support from the RT-PCR and Western blot results, that the expression level of the Ca v 1.2 subtype, and not other Ca v 1 subtypes, was dramatically increased in TGF-␤ 1 -induced, differentiated hASCs (Fig. 3) . Although low-voltage-activated T-type Ca 2ϩ channels are typically expressed at low densities in vascular smooth muscle, the T-type Ca 2ϩ channels play physiological roles in smooth muscle contraction, and therefore, modulating the T-type Ca 2ϩ channels is one strategy to regulate hypertension and angina (13) . For this reason, screening the T-type Ca 2ϩ channel subtypes, the Ca v 3 families, is also essential method to verify the differentiation of vascular SMCs. Our data clearly show that the expression levels of all subtypes of the Ca v 3 family increased during the TGF-␤ 1 -induced differentiation of hASCs. Although our study could not address the increase in the expression of the Ca v 2.3 (R-type, CACNA1E) channel in TGF-␤ 1 -induced, differentiated hASCs, a previous study found Ca v 2.3 channels in the cerebral artery after subarachnoid hemorrhage, which contributed to enhanced cerebral-artery constriction and decreased cerebral blood flow (21) .
Highly expressed BK Ca channels in vascular SMCs regulate arteriolar tone under physiological conditions, and the alteration of BK Ca channels is closely related to vascular diseases such as hypertension, hypertrophy, stroke, atherosclerosis, diabetes, and complications of cardiovascular surgery (14, 19, 27, 38, 39) . The BK Ca channel is composed of four poreforming ␣-subunits (K Ca 1.1) and ancillary ␤-subunits at a 1:1 ratio (29, 58) . A single gene, KCNMA1 (or slo1), encodes the ␣-subunits that form the functional BK Ca channel. A study of ␣-subunit-deleted (Slo1 Ϫ/Ϫ ) mice revealed the absence of iberiotoxin-sensitive current in smooth muscle (41) , suggesting that the increased expression levels and/or appearance of BK Ca -channel ␣-subunits related directly to the increased BK Ca -channel formation and occurrence of BK Ca current. Our results clearly demonstrate an increase in BK Ca channel ␣-subunit (K Ca 1.1) expression levels, with little expression of SK Ca (K Ca 2.X) and IK Ca (K Ca 3.1), and corresponding large iberiotoxin-sensitive outward currents in TGF-␤ 1 -induced differentiated hASCs (Figs. 4 and 5) . The Western blot data strongly support a dramatically increased expression level of the total ␣-subunit in the TGF-␤ 1 -induced, differentiated hASCs. The ␤-subunits of the BK Ca channel reportedly enhance the sensitivity of the channel to voltage and Ca 2ϩ (40) . Four isoforms (KCNMB1-4 or ␤ 1-4 ) are identified as ␤-subunits in mammals. Among those, the ␤ 1 -subunit is highly expressed in smooth muscle including vascular SMCs (24, 38a) . Our results suggest that the ␤ 1 -subunit is highly expressed in both undifferentiated hASCs and TGF-␤ 1 -induced, differentiated hASCs, despite the fact that the expression level of the ␤ 1 -subunit slightly decreased during TGF-␤ 1 -induced differentiation of the hASCs. The Western blot, however, revealed no difference in the total protein levels of the ␤-subunits between the undifferentiated hASCs and the TGF-␤ 1 -induced, differentiated hASCs (Fig.  5) . These results suggest that the ␤-subunits, but not the ␣-subunits, of the BK Ca channel are affluent even in the undifferentiated state. After treatment of the hASCs with TGF-␤ 1 to differentiate them into vascular SMCs, the expression levels of the ␣-subunits dramatically increased, completing the BK Ca -channel structure. Therefore, we observed the large BK Ca current in the TGF-␤ 1 -induced, differentiated hASCs (Fig. 4) . The K v channels consist of pore-forming ␣-subunits and ancillary ␤-subunits, similar to the BK Ca channels (33) . Although many studies addressed the physiological and pharmacological properties of vascular K v channels, few examined the molecular subtypes of the K v channels. Most studies of the molecular subtypes of K v channels examined pulmonary arterial smooth muscle cells (PASMCs). In PASMCs, although other subtypes are controversial, several groups agree on the expression of the K v 1.1, K v 1.2, K v 1.4, K v 1.5, K v 2.1, and K v 9.3 subtypes (3, 9, 10, 51, 67). Our experiment clearly identified the expression of K v 1.1, K v 1.2, K v 1.4, K v 1.5, and K v 9.3, but not K v 2.1, in TGF-␤ 1 -induced, differentiated hASCs. In general, K v current in vascular SMCs slowly and partially decayed with a time constant of ϳ1 s at ϩ40 mV, owing to intrinsic inactivation (48, 52) . Concomitantly, the K v current recorded in the TGF-␤ 1 -induced, differentiated hASCs also showed a similar decay of current with a time constant of ϳ0.5 s at 40 mV. Taken together, the molecular subtypes and the intrinsic inactivation process of the K v channels that we observed suggest that treating hASCs with TGF-␤ 1 causes them to differentiate into vascular SMCs.
TGF-␤ 1 has been reported to induce differentiation of mesenchymal stem cells into SMCs (34, 46, 63) . The present study demonstrated that TGF-␤ 1 increased the expression of the SMC-specific transcription factor myocardin in hASCs. Myocardin plays an important role in the expression of SMCspecific genes by acting as a cofactor for serum-response factor (8a, 12, 65) . It has been reported that mouse embryos lacking myocardin are difficult to survive during the early stage of smooth muscle development and fail to express genes for smooth muscle marker in embryonic dorsal aorta and other vascular structures (36) . Forced expression of myocardin stimulated the expression of SMC markers in human mesenchymal stem cells (60, 61) , whereas dominant negative myocardin mutants and myocardin-specific small interfering RNAs inhibited expression of SMC makers in SMCs (12, 65) . Consistently, we have reported that TGF-␤ 3 -induced expression of ␣-SMA in hASCs was abrogated by small interfering RNAmediated silencing of myocardin and serum-response factor (22) . Therefore, these results suggest that myocardin/serumresponse factor-dependent mechanism plays a key role in TGF-␤ 1 -induced differentiation of hASCs into SMCs. Ca 2ϩ and K ϩ channels play a key role in not only regulation of smooth muscle contractility by eliciting an action potential but also expression of SMC-specific genes (62) . We found that treatment of hASCs with the L-type Ca 2ϩ channel blocker nicardipine, the BK Ca channel blocker iberiotoxin, or the K v channel blockers (4-AP ϩ TEA) during incubation of the cells with TGF-␤ 1 had no significant impact on the differentiation of hASCs into SMCs (Fig. 10) . These results suggest that these ion channels are not implicated in TGF-␤ 1 -induced differentiation of hASCs into SMCs.
In the present study, we demonstrated for the first time that intramuscular injection of TGF-␤ 1 -induced, differentiated hASCs significantly improved blood perfusion and neovascularization in the ischemic limb. Injection of TGF-␤ 1 -treated hASCs increased formation of capillary and arterioles/arteries in ischemic limbs, and they incorporated into ␣-SMA-positive blood vessels. These results, together with the functional expression of ion channels, strongly suggest that TGF-␤ 1 treatment induces differentiation of hASCs into vascular SMCs.
Although further studies of the physiological roles of ion channels in the differentiation of hASCs remain, our study will help to improve stem-cell research and stem-cell therapy in the near future. 
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